TEHRAN — The Trastuzumab with the trade name of Herceptin, a drug mainly used to treat certain breast cancers, will enter the domestic market by the next week, the Food and Drug Administration’s director, Rasoul Dinarvand, said.
 All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.